ADIL Latest Press Releases

-- August 25, 2026 --

Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- August 17, 2026 --

Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- June 16, 2026 --

Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing Globe Newswire 8:00 AM

-- June 11, 2026 --

Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing Globe Newswire 11:43 AM

-- May 11, 2026 --

Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update Globe Newswire 8:30 AM

-- April 29, 2026 --

Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045 Globe Newswire 9:07 AM

-- April 27, 2026 --

Adial Pharmaceuticals Submits Application to FDA Commissioner's National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program Globe Newswire 8:47 AM

-- April 22, 2026 --

Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial Globe Newswire 9:35 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software